Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.
Marshall
G D
GD
Division of Allergy/Immunology, University of Tennessee College of Medicine, Memphis 38146.
D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000637:transplantation; D008222:Lymphokines / Q000276:immunology; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D008222:Lymphokines; D011994:Recombinant Proteins